SLC5A2 and heart failure: These benefits cannot be explained solely by an action of SGLT2 inhibitors to lower blood glucose because similar effects are not seen with glucose-lowering drugs that have a stronger effect on glucose decrease, such as insulin, and because SGLT2 inhibitors also work in patients without diabetes and improve heart failure [134].